bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
PATHADD13

Order Name:
Immunohistochemical stain: Breast markers

 
Useful For:
Analysis in the differential diagnosis of breast lesions as well as for prognosis and prediction
 
Methodology:
Immunohistochemistry
 
Test List In Profile:
ER, PgR, KI-67, HER-2, P53
 
 
 
Test Code:
PATHADD13

Order Name:
Immunohistochemical stain: Breast markers

 
Collection Specimen Or Container:
1. Tissue in 10% neutral buffered formalin or 
2. Paraffin embedded tissue block or
3. Unstained positively charged slides as least 5 slides
 
Specimen Testing Type:
1. Tissue in 10% neutral buffered formalin or 
2. Paraffin embedded tissue block or
3. Unstained positively charged slides as least 5 slides
 
Sub Mission Container:
1. Tissue in 10% neutral buffered formalin or 
2. Paraffin embedded tissue block or
3. Unstained positively charged slides as least 5 slides
 
Rejection Criteria:
1. Wet/ frozen tissue
2. Cytology smears
3. Non formalin fixed tissue
4. Non paraffin embedded tissue
5. Non charged slides
 
Specimen Stabillity:
 
Specimen Type Temperature
Tissue 1. Room temperature for Tissue in 10% neutral buffered formalin
2. Room temperature for paraffin embedded tissue block and unstained slide
(Breast tissue should be fixed in formalin for 6-48 hours, not to exceed 72 hours )
 
 
 
Test Code:
PATHADD13

Order Name:
Immunohistochemical stain: Breast markers

 
Method detail:
Immunohistochemistry
 
Schedule:
Tested daily, at 07:00 am. - 06:00 pm.
 
Turnaround Time:
5-7 days
 
Performing Location:
Surgical Pathology, Laboratory Department Tel.14146
 
Specimen Retention Time:
10 years after final report
 
 
 
Test Code:
PATHADD13

Order Name:
Immunohistochemical stain: Breast markers

 
 
Clinical Information:
Immunohistochemical markers are often used to guide treatment decisions, to classify breast cancer into subtypes that are biologically distinct and behave differently, and both as prognostic and predictive factors.
 
Clinical Reference:
1. https://thepathologist.com/outside-the-lab/a-guide-to-ihc (Retrieved: 1 Feb 2019) 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127609/ (Retrieved 2 Feb 2019)